A dual responsive nitric oxide / β-lapachone co-delivery platform for redox imbalance-enhanced tumor therapy
European Journal of Pharmaceutics and Biopharmaceutics · 2024-08 · 201 · 114348
DOI: 10.1016/j.ejpb.2024.114348 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2024-08. Verfasst von Hui-Zhen Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Green Chemistry and Technology (Ministry of Education), College of Chemistry, Sichuan University, Chengdu 610064, PR China. Hauptthemen laut MEDLINE: Naphthoquinones, Nitric Oxide, Oxidation-Reduction, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Science and Technology Department of Sichuan Province, National Key Research and Development Program of China, Sichuan University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Green Chemistry and Technology (Ministry of Education), College of Chemistry, Sichuan University, Chengdu 610064, PR China.
- Department of Chemistry, University of Virginia, McCormick Rd, Charlottesville, VA 22904, USA.
- Key Laboratory of Green Chemistry and Technology (Ministry of Education), College of Chemistry, Sichuan University, Chengdu 610064, PR China; Asymmetric Synthesis and Chiral Technology Key Laboratory of Sichuan Province…
- Key Laboratory of Green Chemistry and Technology (Ministry of Education), College of Chemistry, Sichuan University, Chengdu 610064, PR China. Electronic address: jzhang@scu.edu.cn.
Förderung
- Science and Technology Department of Sichuan Province
- National Key Research and Development Program of China
- Sichuan University
- National Key Research and Development Program of China Stem Cell and Translational Research
Zitieren
APA
Yang, H. Z., Chen, J. J., Zhang, L., Tian, X. L., Wang, R., Pu, L., Yu, X. Q., & Zhang, J. (2024). A dual responsive nitric oxide / β-lapachone co-delivery platform for redox imbalance-enhanced tumor therapy. European Journal of Pharmaceutics and Biopharmaceutics, 201, 114348. https://doi.org/10.1016/j.ejpb.2024.114348
Vancouver
Yang HZ, Chen JJ, Zhang L, Tian XL, Wang R, Pu L, et al. A dual responsive nitric oxide / β-lapachone co-delivery platform for redox imbalance-enhanced tumor therapy. European Journal of Pharmaceutics and Biopharmaceutics. 2024;201:114348. doi:10.1016/j.ejpb.2024.114348
BibTeX
@article{Yang2024,
author = {Yang, Hui-Zhen and Chen, Jia-Jia and Zhang, Lan and Tian, Xiao-Li and Wang, Rong and Pu, Lin and Yu, Xiao-Qi and Zhang, Ji},
title = {A dual responsive nitric oxide / β-lapachone co-delivery platform for redox imbalance-enhanced tumor therapy},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2024},
volume = {201},
pages = {114348},
doi = {10.1016/j.ejpb.2024.114348}
}
EUVIMED